In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Amedisys Inc (NASDAQ: AMED) closed the day trading at $86.27 down -5.45% from the previous closing price of $91.24. In other words, the price has decreased by -$5.45 from its previous closing price. On the day, 2.13 million shares were traded. AMED stock price reached its highest trading level at $90.0 during the session, while it also had its lowest trading level at $85.84.
Ratios:
For a better understanding of AMED, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.51 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.83. For the most recent quarter (mrq), Quick Ratio is recorded 1.19 and its Current Ratio is at 1.19. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.35.
Truist Downgraded its Buy to Hold on June 07, 2023, while the target price for the stock was maintained at $97.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 07 ’24 when North Michael Paul bought 11,221 shares for $96.80 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMED now has a Market Capitalization of 2825437184 and an Enterprise Value of 3100335104. As of this moment, Amedisys’s Price-to-Earnings (P/E) ratio for their current fiscal year is 34.35, and their Forward P/E ratio for the next fiscal year is 17.54. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.28. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.22 while its Price-to-Book (P/B) ratio in mrq is 2.46. Its current Enterprise Value per Revenue stands at 1.336 whereas that against EBITDA is 13.241.
Stock Price History:
Over the past 52 weeks, AMED has reached a high of $98.95, while it has fallen to a 52-week low of $88.81. The 50-Day Moving Average of the stock is -8.74%, while the 200-Day Moving Average is calculated to be -8.89%.
Shares Statistics:
Over the past 3-months, AMED traded about 440.19K shares per day on average, while over the past 10 days, AMED traded about 341150 shares per day. A total of 32.75M shares are outstanding, with a floating share count of 32.03M. Shares short for AMED as of 1731628800 were 2181193 with a Short Ratio of 4.96, compared to 1728950400 on 1636235. Therefore, it implies a Short% of Shares Outstanding of 2181193 and a Short% of Float of 6.77.
